CN Patent

CN107531646B — 尿嘧啶化合物的结晶

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2020-11-03 · 6y expired

What this patent protects

本发明提供一种口服吸收性良好、特别是能够以良好的重现性获得的结晶。一种(R)－N－(1－(3－(环戊基氧)苯基)乙基)－3－((2,4－二氧代－3,4－二氢嘧啶－1(2H)－基)甲氧基)丙烷－1－磺酰胺的结晶。

USPTO Abstract

本发明提供一种口服吸收性良好、特别是能够以良好的重现性获得的结晶。一种(R)－N－(1－(3－(环戊基氧)苯基)乙基)－3－((2,4－二氧代－3,4－二氢嘧啶－1(2H)－基)甲氧基)丙烷－1－磺酰胺的结晶。

Drugs covered by this patent

Patent Metadata

Patent number: CN107531646B
Jurisdiction: CN
Classification: —
Expires: 2020-11-03
Drug substance claim: No
Drug product claim: No
Assignee: Taiho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.